First-trimester use of ACTs for malaria treatment in pregnancy
- PMID: 36442486
- DOI: 10.1016/S0140-6736(22)02166-3
First-trimester use of ACTs for malaria treatment in pregnancy
Conflict of interest statement
LS chaired a steering committee for a study in which one of the Article authors (F O ter Kuile) was a Principal Investigator, but this was not related to the topic discussed in this Comment. LS is an independent consultant in global health who previously worked for PATH and the US Centers for Disease Control and Prevention. RGFL is a member of the WHO Committee on Guidelines for Treatment of First Trimester Pregnancy. We declare no other competing interests.
Comment on
-
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.Lancet. 2023 Jan 14;401(10371):118-130. doi: 10.1016/S0140-6736(22)01881-5. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
